| Reaction Details |
|---|
 | Report a problem with these data |
| Target | cAMP-specific 3',5'-cyclic phosphodiesterase 7B |
|---|
| Ligand | BDBM50151526 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Scintillation Proximity Assay |
|---|
| pH | 8±n/a |
|---|
| IC50 | 144±n/a nM |
|---|
| Comments | extracted |
|---|
| Citation |  Bergmann, JE; Cutshall, NS; Demopulos, GA; Florio, VA; Gaitanaris, G; Gray, P; Hohmann, J; Onrust, R; Zeng, H Use of PDE7 inhibitors for the treatment of movement disorders US Patent US8637528 Publication Date 1/28/2014 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| cAMP-specific 3',5'-cyclic phosphodiesterase 7B |
|---|
| Name: | cAMP-specific 3',5'-cyclic phosphodiesterase 7B |
|---|
| Synonyms: | 3',5'-cyclic phosphodiesterase | PDE7B | PDE7B_HUMAN | Phosphodiesterase 7B | Phosphodiesterase 7B (PDE7B) | cAMP-specific 3',5'-cyclic phosphodiesterase 7B |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 51842.76 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | Q9NP56 |
|---|
| Residue: | 450 |
|---|
| Sequence: | MSCLMVERCGEILFENPDQNAKCVCMLGDIRLRGQTGVRAERRGSYPFIDFRLLNSTTYS
GEIGTKKKVKRLLSFQRYFHASRLLRGIIPQAPLHLLDEDYLGQARHMLSKVGMWDFDIF
LFDRLTNGNSLVTLLCHLFNTHGLIHHFKLDMVTLHRFLVMVQEDYHSQNPYHNAVHAAD
VTQAMHCYLKEPKLASFLTPLDIMLGLLAAAAHDVDHPGVNQPFLIKTNHHLANLYQNMS
VLENHHWRSTIGMLRESRLLAHLPKEMTQDIEQQLGSLILATDINRQNEFLTRLKAHLHN
KDLRLEDAQDRHFMLQIALKCADICNPCRIWEMSKQWSERVCEEFYRQGELEQKFELEIS
PLCNQQKDSIPSIQIGFMSYIVEPLFREWAHFTGNSTLSENMLGHLAHNKAQWKSLLPRQ
HRSRGSSGSGPDHDHAGQGTESEEQEGDSP
|
|
|
|---|
| BDBM50151526 |
|---|
| n/a |
|---|
| Name | BDBM50151526 |
|---|
| Synonyms: | CHEMBL363097 | N-(4-{5-[(Z)-Cyclohexylimino]-4-methyl-4,5-dihydro-[1,3,4]thiadiazol-2-yl}-phenyl)-acetamide | US8637528, OM956 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C17H22N4OS |
|---|
| Mol. Mass. | 330.448 |
|---|
| SMILES | CC(=O)Nc1ccc(cc1)-c1nn(C)\c(=N\C2CCCCC2)s1 |
|---|
| Structure | 
|
|---|
Search and Browse
